Showing results (661-670 of 9,852) with videos related to

Sort By:
Pageof 986
Arzneimittel-Forschung|April 12, 2000
DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologueP G Baraldi, R Romagnoli, G Spalluto, et al.
Arzneimittel-Forschung|May 23, 2001
Synthesis, evaluation and structure-activity relationships of 5-alkyl-2,3-dihydroimidazo[1,2-c] quinazoline, 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-thiones and their oxo-analogues as new potential bronchodilatorsR H Bahekar, A R Rao
Arzneimittel-Forschung|February 24, 2001
Preparation and pharmacological profile of 2-trifluoromethyl-benzo(8,9)-1,3-diaza-spiro (4,6)-undeca-2,8-diene and its enantiomers as new anti-obesity agentsM F Boussard, J P Guette, M Wierzbicki, et al.
Arzneimittel-Forschung|February 24, 2001
Effect of teprenone on gastric mucosal injury induced by Helicobacter pylori in ratsH Saita, M Murakami
Arzneimittel-Forschung|February 24, 2001
New thiazolo[4,5-d]pyrimidine derivatives as potential antimicrobial agentsH Urgun, A Balkan, M Ozalp
Arzneimittel-Forschung|June 21, 2001
Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitisN Falser, W Wober, V W Rahlfs, et al.
Arzneimittel-Forschung|June 21, 2001
Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 4th communication: tissue distribution, placental transfer and milk secretion of radioactivity in rats after a single oral administration of 14C-NS-49, and effects of repeated administration on its pharmacokineticsP D Dalrymple, T L Beeby, H Mukai, et al.
Arzneimittel-Forschung|June 21, 2001
Tissue distribution of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist, in pigmented ratsT Koike, H Kitazumi, H Mukai
Arzneimittel-Forschung|June 21, 2001
Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activitiesH Küçükbay, R Durmaz, M Güven, et al.
Arzneimittel-Forschung|June 21, 2001
Four-week oral toxicity studies of the new quinolone antibacterial agent cetefloxacin tosylate in rats and marmoset monkeysA Guzmán, C García, A P Marín, et al.
Pageof 986